Sharon Sadowski

5.1k citations

57 papers · 3.2k indexed · 1 hit paper · h-index 27

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology
Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology

Papers in

Cellular and Molecular Neuroscience 31
- Neuropeptides and Animal Physiology 30
Toxicology 4
- Bioactive Compounds and Antitumor Agents 4

Co-authors: F. A. Kuehl John L. Humes Robert J. Bonney Margaret A. Cascieri Philip R. Davies Catherine D. Strader Mary Ellen Dahlgren LM Pelus
Journals: Bioorganic & Medicinal Chemistry Letters (21 papers)Journal of Medicinal Chemistry (10 papers)Journal of Biological Chemistry (5 papers)Molecular Pharmacology (3 papers)Nature (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Sharon Sadowski

57 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Macrophages synthesise and release prostaglandins in response to inflammatory stimuli 1977 · 496 citations

Peers

Countries citing papers authored by Sharon Sadowski

Since Specialization

Citations

This map shows the geographic impact of Sharon Sadowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Sadowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Sadowski more than expected).

Fields of papers citing papers by Sharon Sadowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Sadowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Sadowski. The network helps show where Sharon Sadowski may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sharon Sadowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sharon Sadowski Line = papers co-authored together Sharon Sadowski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cyclopentane-based human NK1 antagonists. Part 2: Development of potent, orally active, water-soluble derivatives Bioorganic & Medicinal Chemistry Letters ·Laura C. Meurer, Paul E. Finke, Karen Owens, Nancy N. Tsou, Richard G. Ball, Sander G. Mills, Malcolm MacCoss, Sharon Sadowski, Margaret A. Cascieri, Kwei‐Lan Tsao, Gary G. Chicchi, Linda A. Egger, Silvi Luell, Joseph M. Metzger, D. Euan MacIntyre, N.M.J. Rupniak, Angela Williams, Richard Hargreaves	2006	21
2	Spirocyclic NK1 antagonists I: [4.5] and [5.5]-Spiroketals Bioorganic & Medicinal Chemistry Letters ·Eileen M. Seward, Emma Carlson, Timothy Harrison, Ignacio. Estay Forno, Richard H. Herbert, Fintan Kelleher, Marc M. Kurtz, Jonathan D. Moseley, Simon N. Owen, Andrew P. Owens, Sharon Sadowski, Christopher J. Swain, Brian J. Williams	2002	22
3	Combinatorial synthesis of 3-(Amidoalkyl) and 3-(Aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors Bioorganic & Medicinal Chemistry Letters ·Christopher A. Willoughby, Steven M. Hutchins, Alberto Bolaños Rivera, N. F. Van der Merwe, Kevin T. Chapman, Gary G. Chicchi, Sharon Sadowski, David H. Weinberg, Smita S. Patel, Lorraine Malkowitz, Jerry Di Salvo, Stephen G Pacholok, Kang Cheng	2002	30
4	The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, M. Cumberbatch, G.S. Mason, Spencer J. Tye, David J. Williamson, Wu Peiyu, Sander G. Mills, Paul E. Finke, Malcolm MacCoss, Sharon Sadowski, E Ber, Margaret A. Cascieri, R.G. Hill, D. Euan MacIntyre, Richard Hargreaves	2000	120
5	Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor Journal of Biological Chemistry ·Margaret A. Cascieri, Gregory Koch, Elżbieta Ber, Sharon Sadowski, Bernhard Sadransky, Stephen E. de Laszlo, 丽连刘, William K. Hagmann, Malcolm MacCoss, Gary G. Chicchi, Pasquale P. Vicario	1999	71
6	High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template Bioorganic & Medicinal Chemistry Letters ·Timothy Harrison, Mads P. G. Korsgaard, Christopher J. Swain, Margaret A. Cascieri, Sharon Sadowski, Guy R. Seabrook	1998	21
7	High affinity phenylglycinol-based NK1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew P. Owens, Timothy Harrison, Jonathan D. Moseley, Christopher J. Swain, Sharon Sadowski, Margaret A. Cascieri	1998	6
8	Serine derived NK1 antagonists 1: The effect of modifications to the serine substituents Bioorganic & Medicinal Chemistry Letters ·Jason Elliott, Margaret A. Cascieri, Gary G. Chicchi, Stephen J. Davies, Fintan Kelleher, Marc M. Kurtz, T. Ladduwahetty, Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant, Sharon Sadowski, Graeme I. Stevenson	1998	7
9	L-tryptophan urea amides as dual antagonists Bioorganic & Medicinal Chemistry Letters ·Hongbo Qi, Shrenik K. Shah, Margaret A. Cascieri, Sharon Sadowski, Malcolm MacCoss	1998	7
10	Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist European Journal of Pharmacology ·Margaret A. Cascieri, Elżbieta Ber, Tung M. Fong, Jeffrey J. Hale, Sérgio R. Borges, Lin‐Lin Shiao, Sander G. Mills, Malcolm MacCoss, Sharon Sadowski, Michael R. Tota, Catherine D. Strader	1997	8
11	In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists European Journal of Pharmacology ·N.M.J. Rupniak, F.D. Tattersall, Angela Williams, Wayne Rycroft, Emma Carlson, Margaret A. Cascieri, Sharon Sadowski, Elżbieta Ber, Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Eileen M. Seward, Ian T. Huscroft, Simon N. Owen, Christopher J. Swain, R.G. Hill, Richard Hargreaves	1997	88
12	Tryptophan-Derived NK1 Antagonists: Conformationally Constrained Heterocyclic Bioisosteres of the Ester Linkage Journal of Medicinal Chemistry ·Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant, Fintan Kelleher, Ian R. Sanderson, Richard H. Herbert, Margaret A. Cascieri, Sharon Sadowski, Richard G. Ball, Karst Hoogsteen	1995	50
13	4,4-Disubstituted Piperidines: A New Class of NK1 Antagonists Journal of Medicinal Chemistry ·Graeme I. Stevenson, Angus M. MacLeod, Ian T. Huscroft, Margaret A. Cascieri, Sharon Sadowski, Raymond Baker	1995	22
14	Synthesis and Biological Evaluation of NK1 Antagonists Derived from L-Tryptophan Journal of Medicinal Chemistry ·Angus M. MacLeod, Margaret A. Cascieri, Kevin J. Merchant, Sharon Sadowski, L. E. Collins, Richard T. Lewis, D. Euan MacIntyre, Joseph M. Metzger, Tung M. Fong	1995	22
15	Identification of L-Tryptophan Derivatives with Potent and Selective Antagonist Activity at the NK1 Receptor Journal of Medicinal Chemistry ·Angus M. MacLeod, Kevin J. Merchant, Frederick A. Brookfield, Fintan Kelleher, Graeme I. Stevenson, Andrew P. Owens, Christopher J. Swain, Margaret A. Cascieri, Sharon Sadowski	1994	52
16	Characterization of the binding of [125I-iodo-histidyl,methyl-Phe7] neurokinin B to the neurokinin-3 receptor Neuropeptides ·Sharon Sadowski, R R Huang, Tung M. Fong, O. Marko, Margaret A. Cascieri	1993	28
17	N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists Journal of Medicinal Chemistry ·Angus M. MacLeod, Kevin J. Merchant, Margaret A. Cascieri, Sharon Sadowski, Elżbieta Ber, 義弘矢端, R. BAKER	1993	58
18	Identification and isolation of a membrane protein necessary for leukotriene production Nature ·Douglas K. Miller, John W. Gillard, Philip J. Vickers, Sharon Sadowski, Claire Leveillé, Joseph A. Mancini, Dinari Nikken, Richard A. F. Dixon, Anthony W. Ford‐Hutchinson, Réjean Fortin, Ronald Calderon, J A Rodkey, J. STEIN, Carol A. Rouzer, Irving S. Sigal, Catherine D. Strader, Jilly F. Evans	1990	382
19	Identification and isolation of medicarpin and a substituted benzofuran as potent leukotriene inhibitors in an anti-inflammatory Chinese herb Prostaglandins Leukotrienes and Essential Fatty Acids ·Dennis K. Miller, Sharon Sadowski, Gas I, H Joshua	1989	15
20	Development of a high capacity microassay for measurement of neutrophil adhesion Journal of Immunological Methods ·Luz Elena Morales Gallego, Sharon Sadowski	1988	8

About Sharon Sadowski

Sharon Sadowski is a scholar working on Cellular and Molecular Neuroscience, Toxicology, Molecular Biology, Immunology and Organic Chemistry, having authored 57 papers that have together received 3.2k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (30 papers), Receptor Mechanisms and Signaling (26 papers), Pharmacological Receptor Mechanisms and Effects (14 papers), Chemical Synthesis and Analysis (9 papers), Immune Cell Function and Interaction (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Synthesis and Biological Evaluation (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (921 citations), Biochemistry (348 citations), Pharmacology (619 citations), Molecular Biology (1.5k citations) and Physiology (519 citations). Sharon Sadowski has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include F. A. Kuehl, John L. Humes, Robert J. Bonney, Margaret A. Cascieri, Philip R. Davies, Catherine D. Strader, Mary Ellen Dahlgren, LM Pelus, Christopher J. Swain and E Ber. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Molecular Pharmacology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact